

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of granulocyte differentiation (GO:0030854) | 4.84343842 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.39607452 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.34482459 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 4.34482459 |
| 5 | regulation of platelet aggregation (GO:0090330) | 4.01854258 |
| 6 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.88144400 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 3.86406889 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85152929 |
| 9 | regulation of female gonad development (GO:2000194) | 3.84028546 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 3.78942758 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 3.72637294 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72152200 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67891295 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 3.67891295 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 3.65695467 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.64402142 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.64402142 |
| 18 | megakaryocyte development (GO:0035855) | 3.62793789 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 3.59262701 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.59262701 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.55952035 |
| 22 | protein carboxylation (GO:0018214) | 3.55952035 |
| 23 | cysteine metabolic process (GO:0006534) | 3.50541866 |
| 24 | low-density lipoprotein particle clearance (GO:0034383) | 3.50509940 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49235841 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.43025671 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 3.41227326 |
| 28 | valine metabolic process (GO:0006573) | 3.39678090 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37871204 |
| 30 | protein neddylation (GO:0045116) | 3.33877740 |
| 31 | lysine metabolic process (GO:0006553) | 3.29729784 |
| 32 | lysine catabolic process (GO:0006554) | 3.29729784 |
| 33 | COPII vesicle coating (GO:0048208) | 3.28943587 |
| 34 | 4-hydroxyproline metabolic process (GO:0019471) | 3.27864167 |
| 35 | positive regulation of macrophage differentiation (GO:0045651) | 3.27421511 |
| 36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.25509293 |
| 37 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.23883007 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23484690 |
| 39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22414735 |
| 40 | hypotonic response (GO:0006971) | 3.18495502 |
| 41 | hepatocyte apoptotic process (GO:0097284) | 3.17803883 |
| 42 | regulation of platelet activation (GO:0010543) | 3.16987225 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 3.16391197 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.16304612 |
| 45 | complement activation, alternative pathway (GO:0006957) | 3.16001302 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 3.15262849 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.12740732 |
| 48 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10796320 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10796320 |
| 50 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.10573134 |
| 51 | microtubule severing (GO:0051013) | 3.10007030 |
| 52 | regulation of fibrinolysis (GO:0051917) | 3.07048260 |
| 53 | B cell proliferation (GO:0042100) | 3.06206784 |
| 54 | regulation of protein activation cascade (GO:2000257) | 3.05866817 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.04140561 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.03341564 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.03341564 |
| 58 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.03165919 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.02062197 |
| 60 | oxygen transport (GO:0015671) | 3.01185349 |
| 61 | urea metabolic process (GO:0019627) | 2.99061670 |
| 62 | urea cycle (GO:0000050) | 2.99061670 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 2.96905589 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96620903 |
| 65 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.96540465 |
| 66 | regulation of complement activation (GO:0030449) | 2.93563427 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92305343 |
| 68 | positive regulation of nuclease activity (GO:0032075) | 2.91510547 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90676067 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 2.89186763 |
| 71 | platelet aggregation (GO:0070527) | 2.88980172 |
| 72 | homocysteine metabolic process (GO:0050667) | 2.88852930 |
| 73 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.88778843 |
| 74 | histone mRNA catabolic process (GO:0071044) | 2.88095164 |
| 75 | negative T cell selection (GO:0043383) | 2.87925187 |
| 76 | peptide catabolic process (GO:0043171) | 2.87460099 |
| 77 | fibrinolysis (GO:0042730) | 2.87200128 |
| 78 | kynurenine metabolic process (GO:0070189) | 2.87166580 |
| 79 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.85929497 |
| 80 | negative regulation of stress fiber assembly (GO:0051497) | 2.85428345 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 2.85329255 |
| 82 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.84383798 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.84173427 |
| 84 | reverse cholesterol transport (GO:0043691) | 2.83335484 |
| 85 | protein targeting to Golgi (GO:0000042) | 2.83002271 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 2.82999181 |
| 87 | apoptotic cell clearance (GO:0043277) | 2.82132911 |
| 88 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.81683951 |
| 89 | tyrosine metabolic process (GO:0006570) | 2.81616589 |
| 90 | protein retention in ER lumen (GO:0006621) | 2.80455490 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.80396596 |
| 92 | positive regulation of isotype switching (GO:0045830) | 2.79656673 |
| 93 | regulation of granulocyte differentiation (GO:0030852) | 2.78954909 |
| 94 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.78675251 |
| 95 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.77604110 |
| 96 | tryptophan metabolic process (GO:0006568) | 2.77165448 |
| 97 | cell adhesion mediated by integrin (GO:0033627) | 2.75857955 |
| 98 | * cellular response to unfolded protein (GO:0034620) | 2.75596884 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.75029834 |
| 100 | regulation of histone H3-K9 methylation (GO:0051570) | 2.74160283 |
| 101 | macroautophagy (GO:0016236) | 2.73380613 |
| 102 | negative regulation of sterol transport (GO:0032372) | 2.73047517 |
| 103 | negative regulation of cholesterol transport (GO:0032375) | 2.73047517 |
| 104 | multicellular organism reproduction (GO:0032504) | 2.72825583 |
| 105 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.72817833 |
| 106 | positive T cell selection (GO:0043368) | 2.72626117 |
| 107 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70045862 |
| 108 | ER-nucleus signaling pathway (GO:0006984) | 2.69684188 |
| 109 | regulation of cholesterol storage (GO:0010885) | 2.68795235 |
| 110 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.68777585 |
| 111 | indole-containing compound catabolic process (GO:0042436) | 2.68602291 |
| 112 | indolalkylamine catabolic process (GO:0046218) | 2.68602291 |
| 113 | tryptophan catabolic process (GO:0006569) | 2.68602291 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 2.68500087 |
| 115 | glyoxylate metabolic process (GO:0046487) | 2.68498163 |
| 116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67723305 |
| 117 | bile acid biosynthetic process (GO:0006699) | 2.67214373 |
| 118 | regulation of nuclease activity (GO:0032069) | 2.66691345 |
| 119 | angiogenesis involved in wound healing (GO:0060055) | 2.66454317 |
| 120 | polyamine biosynthetic process (GO:0006596) | 2.65305032 |
| 121 | phospholipid homeostasis (GO:0055091) | 2.64921455 |
| 122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63309639 |
| 123 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.62613266 |
| 124 | gas transport (GO:0015669) | 2.62507715 |
| 125 | tricarboxylic acid metabolic process (GO:0072350) | 2.62435218 |
| 126 | positive regulation of blood coagulation (GO:0030194) | 2.62040413 |
| 127 | positive regulation of hemostasis (GO:1900048) | 2.62040413 |
| 128 | skin morphogenesis (GO:0043589) | 2.61774098 |
| 129 | histone H3-K36 demethylation (GO:0070544) | 2.61563184 |
| 130 | nitrogen cycle metabolic process (GO:0071941) | 2.61257015 |
| 131 | positive regulation of coagulation (GO:0050820) | 2.60874509 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.59263725 |
| 133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.58564071 |
| 134 | carnitine metabolic process (GO:0009437) | 2.57768056 |
| 135 | * cellular response to topologically incorrect protein (GO:0035967) | 2.57679706 |
| 136 | macrophage activation involved in immune response (GO:0002281) | 2.56809116 |
| 137 | plasma lipoprotein particle assembly (GO:0034377) | 2.56411495 |
| 138 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.56398750 |
| 139 | positive regulation of B cell mediated immunity (GO:0002714) | 2.56157263 |
| 140 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.56157263 |
| 141 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55568652 |
| 142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55530773 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.55423567 |
| 144 | acute-phase response (GO:0006953) | 2.55361448 |
| 145 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.55183329 |
| 146 | 2-oxoglutarate metabolic process (GO:0006103) | 2.54651174 |
| 147 | lipoprotein metabolic process (GO:0042157) | 2.54566765 |
| 148 | phospholipid efflux (GO:0033700) | 2.54178083 |
| 149 | protein-lipid complex assembly (GO:0065005) | 2.53876205 |
| 150 | acylglycerol homeostasis (GO:0055090) | 2.53630183 |
| 151 | triglyceride homeostasis (GO:0070328) | 2.53630183 |
| 152 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.52788268 |
| 153 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52443865 |
| 154 | regulation of integrin activation (GO:0033623) | 2.52261334 |
| 155 | hormone catabolic process (GO:0042447) | 2.51999783 |
| 156 | protein-lipid complex remodeling (GO:0034368) | 2.51887219 |
| 157 | macromolecular complex remodeling (GO:0034367) | 2.51887219 |
| 158 | plasma lipoprotein particle remodeling (GO:0034369) | 2.51887219 |
| 159 | positive regulation of DNA recombination (GO:0045911) | 2.51716140 |
| 160 | positive regulation of B cell differentiation (GO:0045579) | 2.51194837 |
| 161 | fatty acid oxidation (GO:0019395) | 2.50206178 |
| 162 | epithelial cilium movement (GO:0003351) | 2.49996321 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.49431461 |
| 164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49431461 |
| 165 | modulation by symbiont of host defense response (GO:0052031) | 2.49431461 |
| 166 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49431461 |
| 167 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49431461 |
| 168 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49431461 |
| 169 | myeloid cell development (GO:0061515) | 2.49366835 |
| 170 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.49036437 |
| 171 | myeloid cell activation involved in immune response (GO:0002275) | 2.48655626 |
| 172 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.47018742 |
| 173 | bile acid metabolic process (GO:0008206) | 2.46284817 |
| 174 | lipid oxidation (GO:0034440) | 2.45396252 |
| 175 | epoxygenase P450 pathway (GO:0019373) | 2.45375514 |
| 176 | actin nucleation (GO:0045010) | 2.44470656 |
| 177 | negative regulation of T cell apoptotic process (GO:0070233) | 2.43474349 |
| 178 | fatty acid beta-oxidation (GO:0006635) | 2.42517253 |
| 179 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42081089 |
| 180 | aromatic amino acid family metabolic process (GO:0009072) | 2.41814511 |
| 181 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.41505022 |
| 182 | regulation of memory T cell differentiation (GO:0043380) | 2.40542761 |
| 183 | termination of signal transduction (GO:0023021) | 2.40091251 |
| 184 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.39370281 |
| 185 | interkinetic nuclear migration (GO:0022027) | 2.38842066 |
| 186 | cilium movement (GO:0003341) | 2.37654925 |
| 187 | B cell mediated immunity (GO:0019724) | 2.37053832 |
| 188 | positive regulation of type 2 immune response (GO:0002830) | 2.35809482 |
| 189 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.35458486 |
| 190 | autophagic vacuole fusion (GO:0000046) | 2.35447383 |
| 191 | definitive hemopoiesis (GO:0060216) | 2.35249982 |
| 192 | regulation of interleukin-8 secretion (GO:2000482) | 2.34236377 |
| 193 | regulation of B cell differentiation (GO:0045577) | 2.33926127 |
| 194 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32716896 |
| 195 | T cell selection (GO:0045058) | 2.30955076 |
| 196 | detection of other organism (GO:0098543) | 2.30521589 |
| 197 | neutrophil activation (GO:0042119) | 2.30272299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.75832397 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.29805351 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06052340 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.65948173 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.29025215 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05067712 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.05016558 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.77902525 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76971358 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53250437 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49180709 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47729453 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.43797298 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31336866 |
| 15 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.25255536 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25219695 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22666784 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19498929 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18930475 |
| 20 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.15828236 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03206394 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01329787 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99145943 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95004403 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94743263 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94713547 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.93823053 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93476336 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89368003 |
| 30 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.87607658 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82775229 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81503305 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79991593 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.79653432 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77148018 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73990755 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73795842 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72452582 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71442127 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69857099 |
| 41 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69524955 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63012607 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59767545 |
| 44 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59407880 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57373333 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55811840 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54390883 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54233526 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53900373 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52182588 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48705487 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43484497 |
| 53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43202211 |
| 54 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.39546998 |
| 55 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.39517187 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39199610 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.37575511 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37253615 |
| 59 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35198588 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33553449 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32870042 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31733641 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30996410 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30391027 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28263350 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27472606 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27015349 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26456038 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26352799 |
| 70 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.26318758 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25729006 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25184279 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24574447 |
| 74 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24315254 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23768968 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22963974 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22676527 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22121584 |
| 79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21355606 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21276592 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21194549 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19608405 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19587380 |
| 84 | * MYB_26560356_Chip-Seq_TH2_Human | 1.18311203 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16431075 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16319753 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16318641 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14813680 |
| 89 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14008041 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13497410 |
| 91 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.13336316 |
| 92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12301116 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11496022 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11457557 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11236159 |
| 96 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10920666 |
| 97 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10920666 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 1.09252041 |
| 99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.08591330 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.08441263 |
| 101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06951300 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.05477814 |
| 103 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04076657 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03493742 |
| 105 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03192815 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02625237 |
| 107 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02162920 |
| 108 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02130326 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01597772 |
| 110 | MYC_22102868_ChIP-Seq_BL_Human | 1.01519910 |
| 111 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01019127 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99955541 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99196240 |
| 114 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98945596 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98900543 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98548558 |
| 117 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98159641 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97943980 |
| 119 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97769060 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96951145 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96778818 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96778818 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96117115 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96051139 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95753163 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95516159 |
| 127 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94887322 |
| 128 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94641698 |
| 129 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94312402 |
| 130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94264305 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93348237 |
| 132 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93153159 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92880561 |
| 134 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92467202 |
| 135 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92325068 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92220350 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92216380 |
| 138 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92178622 |
| 139 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91980375 |
| 140 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91663759 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91198231 |
| 142 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90714938 |
| 143 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90445739 |
| 144 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90161070 |
| 145 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88924227 |
| 146 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88822975 |
| 147 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.88820646 |
| 148 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.88319923 |
| 149 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87964962 |
| 150 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86788469 |
| 151 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85579706 |
| 152 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85458784 |
| 153 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85001259 |
| 154 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84989681 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84816377 |
| 156 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84739235 |
| 157 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84553642 |
| 158 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84357187 |
| 159 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83167444 |
| 160 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82164714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.74863293 |
| 2 | MP0005365_abnormal_bile_salt | 3.32620851 |
| 3 | MP0005360_urolithiasis | 3.22395247 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.21845096 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.77439014 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.71204424 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.61992887 |
| 8 | MP0003252_abnormal_bile_duct | 2.57369970 |
| 9 | MP0009840_abnormal_foam_cell | 2.39134138 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.38710445 |
| 11 | MP0008004_abnormal_stomach_pH | 2.25433289 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.24700389 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.09175628 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.07983357 |
| 15 | MP0005083_abnormal_biliary_tract | 2.06442204 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06067820 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.96443326 |
| 18 | MP0005410_abnormal_fertilization | 1.89046905 |
| 19 | MP0002398_abnormal_bone_marrow | 1.88989810 |
| 20 | MP0001666_abnormal_nutrient_absorption | 1.87379319 |
| 21 | MP0003195_calcinosis | 1.85459933 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.85208573 |
| 23 | MP0005671_abnormal_response_to | 1.83017767 |
| 24 | MP0000689_abnormal_spleen_morphology | 1.79634835 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.72362902 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.70932359 |
| 27 | MP0000609_abnormal_liver_physiology | 1.70034456 |
| 28 | MP0001819_abnormal_immune_cell | 1.68378595 |
| 29 | MP0003436_decreased_susceptibility_to | 1.64707266 |
| 30 | MP0005310_abnormal_salivary_gland | 1.58963439 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.56169631 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.54745054 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.54455056 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.49290131 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.47985920 |
| 36 | MP0000716_abnormal_immune_system | 1.47220001 |
| 37 | MP0004947_skin_inflammation | 1.46342122 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.45103208 |
| 39 | MP0005023_abnormal_wound_healing | 1.41702196 |
| 40 | MP0006054_spinal_hemorrhage | 1.41467218 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.39074737 |
| 42 | MP0002009_preneoplasia | 1.38659529 |
| 43 | MP0002429_abnormal_blood_cell | 1.36809180 |
| 44 | MP0008057_abnormal_DNA_replication | 1.35684303 |
| 45 | MP0002722_abnormal_immune_system | 1.35661644 |
| 46 | MP0005275_abnormal_skin_tensile | 1.34902584 |
| 47 | MP0003718_maternal_effect | 1.33708337 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.33231924 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.30737492 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.30277178 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 1.29650861 |
| 52 | MP0005332_abnormal_amino_acid | 1.29593350 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.28507623 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.28447771 |
| 55 | MP0002405_respiratory_system_inflammati | 1.26850047 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.26743997 |
| 57 | MP0003828_pulmonary_edema | 1.24899900 |
| 58 | MP0003303_peritoneal_inflammation | 1.21170003 |
| 59 | MP0006082_CNS_inflammation | 1.19723758 |
| 60 | MP0002060_abnormal_skin_morphology | 1.18567064 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.17815009 |
| 62 | MP0003279_aneurysm | 1.16459567 |
| 63 | MP0008775_abnormal_heart_ventricle | 1.15828459 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.14702498 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.14433473 |
| 66 | MP0005164_abnormal_response_to | 1.14365096 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.10980920 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.09345014 |
| 69 | MP0000598_abnormal_liver_morphology | 1.08882907 |
| 70 | MP0008469_abnormal_protein_level | 1.08330515 |
| 71 | MP0002419_abnormal_innate_immunity | 1.06484187 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.06180659 |
| 73 | MP0002928_abnormal_bile_duct | 1.06140298 |
| 74 | MP0000685_abnormal_immune_system | 1.05966476 |
| 75 | MP0003868_abnormal_feces_composition | 1.02533192 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.01905681 |
| 77 | MP0005670_abnormal_white_adipose | 1.00928958 |
| 78 | MP0009764_decreased_sensitivity_to | 1.00736446 |
| 79 | MP0005257_abnormal_intraocular_pressure | 1.00460914 |
| 80 | MP0004883_abnormal_blood_vessel | 0.99553653 |
| 81 | MP0003950_abnormal_plasma_membrane | 0.99225565 |
| 82 | MP0000858_altered_metastatic_potential | 0.98233125 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.97853933 |
| 84 | MP0000343_altered_response_to | 0.97137327 |
| 85 | MP0004036_abnormal_muscle_relaxation | 0.97116807 |
| 86 | MP0003724_increased_susceptibility_to | 0.97036427 |
| 87 | MP0000249_abnormal_blood_vessel | 0.96477220 |
| 88 | MP0010307_abnormal_tumor_latency | 0.94979559 |
| 89 | MP0004134_abnormal_chest_morphology | 0.94834410 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.94714646 |
| 91 | MP0003091_abnormal_cell_migration | 0.94137938 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.93831189 |
| 93 | MP0004484_altered_response_of | 0.92721583 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.92284056 |
| 95 | MP0002132_abnormal_respiratory_system | 0.91662236 |
| 96 | MP0001790_abnormal_immune_system | 0.90757777 |
| 97 | MP0005387_immune_system_phenotype | 0.90757777 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.90566005 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.90566005 |
| 100 | MP0009785_altered_susceptibility_to | 0.90554408 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.90495174 |
| 102 | MP0002933_joint_inflammation | 0.90407375 |
| 103 | MP0004130_abnormal_muscle_cell | 0.90250145 |
| 104 | MP0000604_amyloidosis | 0.89484347 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.89296715 |
| 106 | MP0009763_increased_sensitivity_to | 0.89113861 |
| 107 | MP0002896_abnormal_bone_mineralization | 0.88812547 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.88425682 |
| 109 | MP0001873_stomach_inflammation | 0.88319350 |
| 110 | MP0004381_abnormal_hair_follicle | 0.88187959 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.86558923 |
| 112 | MP0003186_abnormal_redox_activity | 0.84675523 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.84129900 |
| 114 | MP0001661_extended_life_span | 0.84018701 |
| 115 | MP0005000_abnormal_immune_tolerance | 0.83873287 |
| 116 | MP0001944_abnormal_pancreas_morphology | 0.83691128 |
| 117 | MP0008260_abnormal_autophagy | 0.83598365 |
| 118 | MP0001542_abnormal_bone_strength | 0.83420341 |
| 119 | MP0001800_abnormal_humoral_immune | 0.82226400 |
| 120 | MP0002254_reproductive_system_inflammat | 0.81983023 |
| 121 | MP0003787_abnormal_imprinting | 0.81879326 |
| 122 | MP0005025_abnormal_response_to | 0.81879317 |
| 123 | MP0005395_other_phenotype | 0.79861891 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.79546029 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.79325930 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.78892975 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.78868484 |
| 128 | MP0005408_hypopigmentation | 0.78402058 |
| 129 | MP0002452_abnormal_antigen_presenting | 0.78330633 |
| 130 | MP0003866_abnormal_defecation | 0.77927236 |
| 131 | MP0003045_fibrosis | 0.77471492 |
| 132 | MP0001243_abnormal_dermal_layer | 0.76942235 |
| 133 | MP0002168_other_aberrant_phenotype | 0.76464224 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.75531791 |
| 135 | MP0004019_abnormal_vitamin_homeostasis | 0.75132732 |
| 136 | MP0009115_abnormal_fat_cell | 0.75077020 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.74925222 |
| 138 | MP0001929_abnormal_gametogenesis | 0.74684256 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74491970 |
| 140 | MP0005503_abnormal_tendon_morphology | 0.73899670 |
| 141 | MP0001958_emphysema | 0.73757579 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.73364532 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.73076103 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.72950761 |
| 145 | MP0002006_tumorigenesis | 0.72784471 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.71554315 |
| 147 | MP0002723_abnormal_immune_serum | 0.71282145 |
| 148 | MP0005174_abnormal_tail_pigmentation | 0.70980352 |
| 149 | MP0001851_eye_inflammation | 0.70657503 |
| 150 | MP0003448_altered_tumor_morphology | 0.70568585 |
| 151 | MP0004147_increased_porphyrin_level | 0.69942417 |
| 152 | MP0002971_abnormal_brown_adipose | 0.69531887 |
| 153 | MP0003795_abnormal_bone_structure | 0.69405458 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.66440878 |
| 155 | MP0000465_gastrointestinal_hemorrhage | 0.65730981 |
| 156 | MP0005390_skeleton_phenotype | 0.65110627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 6.02069050 |
| 2 | Petechiae (HP:0000967) | 4.62420359 |
| 3 | Epistaxis (HP:0000421) | 4.55098147 |
| 4 | Poikilocytosis (HP:0004447) | 4.37585025 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.35026208 |
| 6 | Purpura (HP:0000979) | 4.20379693 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.94526092 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.87350586 |
| 9 | Xanthomatosis (HP:0000991) | 3.78505275 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60138768 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 3.50030249 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.49329489 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48480846 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.43603047 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.40452880 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 3.36857001 |
| 17 | Myocardial infarction (HP:0001658) | 3.35976425 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.28783827 |
| 19 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.27102501 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.26767419 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.25045756 |
| 22 | Abnormal platelet function (HP:0011869) | 3.19035116 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.19035116 |
| 24 | T lymphocytopenia (HP:0005403) | 3.15988576 |
| 25 | Acanthocytosis (HP:0001927) | 3.14600854 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.09946081 |
| 27 | Complement deficiency (HP:0004431) | 3.05744242 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03384096 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.02399751 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.86932269 |
| 31 | Chronic hepatic failure (HP:0100626) | 2.85340202 |
| 32 | Bronchitis (HP:0012387) | 2.81656690 |
| 33 | Dysostosis multiplex (HP:0000943) | 2.79288902 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.76805459 |
| 35 | Mucopolysacchariduria (HP:0008155) | 2.75436090 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75436090 |
| 37 | Tubulointerstitial nephritis (HP:0001970) | 2.74444383 |
| 38 | Gastrointestinal stroma tumor (HP:0100723) | 2.74400419 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 2.73316147 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.73270872 |
| 41 | Recurrent sinusitis (HP:0011108) | 2.71101201 |
| 42 | Thrombocytosis (HP:0001894) | 2.67679553 |
| 43 | Colitis (HP:0002583) | 2.67345620 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 2.66832287 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.63695032 |
| 46 | Ketosis (HP:0001946) | 2.63314459 |
| 47 | Fat malabsorption (HP:0002630) | 2.62674766 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.62672926 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60265570 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60265570 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60265570 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.60221472 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.59438972 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58530128 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.58530128 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.58018026 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.57234693 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56445525 |
| 59 | Rhinitis (HP:0012384) | 2.55827700 |
| 60 | Renal cortical cysts (HP:0000803) | 2.55524400 |
| 61 | Osteomyelitis (HP:0002754) | 2.54630346 |
| 62 | Abnormality of complement system (HP:0005339) | 2.53497755 |
| 63 | Joint hemorrhage (HP:0005261) | 2.52156141 |
| 64 | Recurrent viral infections (HP:0004429) | 2.49209452 |
| 65 | Abnormal ciliary motility (HP:0012262) | 2.48671732 |
| 66 | Esophageal varix (HP:0002040) | 2.46789301 |
| 67 | Bruising susceptibility (HP:0000978) | 2.46290499 |
| 68 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.45055035 |
| 69 | Vasculitis (HP:0002633) | 2.44301681 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.42625250 |
| 71 | Epidermoid cyst (HP:0200040) | 2.42220720 |
| 72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.41511044 |
| 73 | Abnormality of the renal cortex (HP:0011035) | 2.36794599 |
| 74 | Lymphopenia (HP:0001888) | 2.36125452 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.32410002 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.32410002 |
| 77 | Aortic aneurysm (HP:0004942) | 2.31909315 |
| 78 | Absent/shortened dynein arms (HP:0200106) | 2.31626010 |
| 79 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.31626010 |
| 80 | Peritonitis (HP:0002586) | 2.31441683 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.31264888 |
| 82 | Upper limb muscle weakness (HP:0003484) | 2.30824806 |
| 83 | Skin nodule (HP:0200036) | 2.30681691 |
| 84 | Tetraparesis (HP:0002273) | 2.29566822 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.29540616 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28737390 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28319608 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.26910976 |
| 89 | Ketoacidosis (HP:0001993) | 2.26173567 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24974259 |
| 91 | Cervical subluxation (HP:0003308) | 2.24963107 |
| 92 | Hypercholesterolemia (HP:0003124) | 2.23098705 |
| 93 | Nasal polyposis (HP:0100582) | 2.19597546 |
| 94 | Paralysis (HP:0003470) | 2.19266880 |
| 95 | Bronchiectasis (HP:0002110) | 2.17417271 |
| 96 | Abnormality of T cells (HP:0002843) | 2.16625907 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.16472374 |
| 98 | Microcytic anemia (HP:0001935) | 2.15876434 |
| 99 | Chronic diarrhea (HP:0002028) | 2.14853211 |
| 100 | IgM deficiency (HP:0002850) | 2.13573123 |
| 101 | Hyperammonemia (HP:0001987) | 2.12167965 |
| 102 | Cellulitis (HP:0100658) | 2.12017671 |
| 103 | IgA deficiency (HP:0002720) | 2.10709172 |
| 104 | Right ventricular cardiomyopathy (HP:0011663) | 2.10568150 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.08634791 |
| 106 | Chest pain (HP:0100749) | 2.06867754 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 2.06707284 |
| 108 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05633259 |
| 109 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05633259 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05164123 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 2.04734568 |
| 112 | Abnormal pancreas size (HP:0012094) | 2.04203563 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 2.03848126 |
| 114 | Meningitis (HP:0001287) | 2.03336623 |
| 115 | Hematochezia (HP:0002573) | 2.02714623 |
| 116 | Anhidrosis (HP:0000970) | 2.02421405 |
| 117 | Steatorrhea (HP:0002570) | 2.02227896 |
| 118 | Cardiovascular calcification (HP:0011915) | 2.01549056 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 2.01383696 |
| 120 | Recurrent abscess formation (HP:0002722) | 2.00608237 |
| 121 | Aneurysm (HP:0002617) | 1.98942965 |
| 122 | Osteomalacia (HP:0002749) | 1.98025839 |
| 123 | Menorrhagia (HP:0000132) | 1.97611255 |
| 124 | Portal hypertension (HP:0001409) | 1.96873141 |
| 125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96646167 |
| 126 | Albinism (HP:0001022) | 1.95920995 |
| 127 | Recurrent pneumonia (HP:0006532) | 1.95814372 |
| 128 | Mitral stenosis (HP:0001718) | 1.95296992 |
| 129 | Short nail (HP:0001799) | 1.94986090 |
| 130 | Abnormal foot bone ossification (HP:0010675) | 1.94344683 |
| 131 | Obstructive lung disease (HP:0006536) | 1.94319366 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94319366 |
| 133 | Recurrent fungal infections (HP:0002841) | 1.94081363 |
| 134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93066351 |
| 135 | Vascular calcification (HP:0004934) | 1.92979705 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.92067882 |
| 137 | Increased mean platelet volume (HP:0011877) | 1.91795057 |
| 138 | Lymphoma (HP:0002665) | 1.91619391 |
| 139 | Chronic bronchitis (HP:0004469) | 1.91552899 |
| 140 | Glomerulonephritis (HP:0000099) | 1.91535156 |
| 141 | Late onset (HP:0003584) | 1.91261076 |
| 142 | Menstrual irregularities (HP:0000858) | 1.91160971 |
| 143 | Hyperglycemia (HP:0003074) | 1.90990993 |
| 144 | Enlarged kidneys (HP:0000105) | 1.90988381 |
| 145 | Papillary thyroid carcinoma (HP:0002895) | 1.90638752 |
| 146 | Gingival bleeding (HP:0000225) | 1.89685692 |
| 147 | Abnormality of purine metabolism (HP:0004352) | 1.89650468 |
| 148 | Amaurosis fugax (HP:0100576) | 1.89516843 |
| 149 | Emphysema (HP:0002097) | 1.89227873 |
| 150 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88332575 |
| 151 | Aortic dissection (HP:0002647) | 1.87654902 |
| 152 | Protuberant abdomen (HP:0001538) | 1.85380126 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.84528266 |
| 154 | Recurrent otitis media (HP:0000403) | 1.84297812 |
| 155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83942655 |
| 156 | Pancreatitis (HP:0001733) | 1.83368524 |
| 157 | Verrucae (HP:0200043) | 1.82861068 |
| 158 | Papilloma (HP:0012740) | 1.82861068 |
| 159 | Chronic sinusitis (HP:0011109) | 1.81533734 |
| 160 | Ileus (HP:0002595) | 1.81025420 |
| 161 | Abnormal platelet volume (HP:0011876) | 1.80253856 |
| 162 | Metaphyseal dysplasia (HP:0100255) | 1.80250628 |
| 163 | Spondylolisthesis (HP:0003302) | 1.80093295 |
| 164 | Leukocytosis (HP:0001974) | 1.78862071 |
| 165 | Arterial thrombosis (HP:0004420) | 1.78714058 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.78156698 |
| 167 | Global brain atrophy (HP:0002283) | 1.78132684 |
| 168 | Nephritis (HP:0000123) | 1.76958259 |
| 169 | Pustule (HP:0200039) | 1.76938709 |
| 170 | Recurrent lower respiratory tract infections (HP:0002783) | 1.76757411 |
| 171 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75753066 |
| 172 | Male infertility (HP:0003251) | 1.75694508 |
| 173 | Increased density of long bones (HP:0006392) | 1.75366411 |
| 174 | Nonimmune hydrops fetalis (HP:0001790) | 1.75161731 |
| 175 | Spastic diplegia (HP:0001264) | 1.74060561 |
| 176 | Mucosal telangiectasiae (HP:0100579) | 1.73909461 |
| 177 | Back pain (HP:0003418) | 1.70248665 |
| 178 | Symptomatic seizures (HP:0011145) | 1.70129088 |
| 179 | Polycythemia (HP:0001901) | 1.70049538 |
| 180 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69549783 |
| 181 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68960512 |
| 182 | Conjunctival telangiectasia (HP:0000524) | 1.68664434 |
| 183 | Eczematoid dermatitis (HP:0000976) | 1.68579522 |
| 184 | Subacute progressive viral hepatitis (HP:0006572) | 1.68034637 |
| 185 | Beaking of vertebral bodies (HP:0004568) | 1.67526545 |
| 186 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67332132 |
| 187 | Abnormality of methionine metabolism (HP:0010901) | 1.66968832 |
| 188 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.66938447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.54163084 |
| 2 | ERN1 | 3.99930400 |
| 3 | TRIB3 | 3.78251495 |
| 4 | RIPK4 | 3.13058948 |
| 5 | PKN2 | 2.85369747 |
| 6 | TAOK3 | 2.63085576 |
| 7 | SIK1 | 2.50728845 |
| 8 | EPHA2 | 2.45110097 |
| 9 | BCKDK | 2.20657278 |
| 10 | TXK | 2.11541765 |
| 11 | TTN | 2.10386508 |
| 12 | MYLK | 2.09452861 |
| 13 | STK24 | 2.07869792 |
| 14 | GRK6 | 2.05189244 |
| 15 | EIF2AK1 | 2.02138694 |
| 16 | LATS1 | 1.92441387 |
| 17 | IRAK3 | 1.91496959 |
| 18 | FGFR4 | 1.89884275 |
| 19 | PTK6 | 1.89538933 |
| 20 | FRK | 1.88899031 |
| 21 | STK10 | 1.87780276 |
| 22 | TBK1 | 1.80900216 |
| 23 | TYK2 | 1.76014925 |
| 24 | PTK2B | 1.75314879 |
| 25 | SYK | 1.74504397 |
| 26 | EEF2K | 1.67641461 |
| 27 | MAP3K3 | 1.66732971 |
| 28 | MST1R | 1.66191081 |
| 29 | TGFBR2 | 1.60799233 |
| 30 | LRRK2 | 1.60020318 |
| 31 | NLK | 1.59620442 |
| 32 | BRSK2 | 1.55383134 |
| 33 | MAP3K13 | 1.52905177 |
| 34 | MAP3K9 | 1.51995828 |
| 35 | MAP4K1 | 1.49136107 |
| 36 | JAK3 | 1.45458777 |
| 37 | FLT3 | 1.41048550 |
| 38 | JAK1 | 1.37687572 |
| 39 | PLK4 | 1.32668096 |
| 40 | MAP4K2 | 1.32241024 |
| 41 | NEK9 | 1.31687622 |
| 42 | EPHB1 | 1.31105157 |
| 43 | ZAP70 | 1.27395181 |
| 44 | STK3 | 1.25186648 |
| 45 | RPS6KA4 | 1.22849512 |
| 46 | RIPK1 | 1.20884003 |
| 47 | EPHA3 | 1.20450797 |
| 48 | BRAF | 1.19562573 |
| 49 | DYRK1B | 1.19405499 |
| 50 | MAP2K3 | 1.18910384 |
| 51 | BMPR2 | 1.17234382 |
| 52 | ACVR1B | 1.15995184 |
| 53 | INSRR | 1.15505602 |
| 54 | TESK1 | 1.15151855 |
| 55 | CDK12 | 1.14790924 |
| 56 | MAP3K14 | 1.14028758 |
| 57 | LYN | 1.11626850 |
| 58 | MAP3K10 | 1.09329888 |
| 59 | PDK4 | 1.07730658 |
| 60 | PDK3 | 1.07730658 |
| 61 | ARAF | 1.06998383 |
| 62 | WNK1 | 1.06371143 |
| 63 | CAMK1D | 1.05749223 |
| 64 | FGR | 1.03775984 |
| 65 | RAF1 | 1.03030130 |
| 66 | MELK | 1.01627977 |
| 67 | PDGFRA | 1.00894524 |
| 68 | CDK6 | 1.00379824 |
| 69 | SCYL2 | 1.00120358 |
| 70 | PIK3CG | 0.99281372 |
| 71 | AKT3 | 0.98985679 |
| 72 | EIF2AK3 | 0.98465788 |
| 73 | MARK2 | 0.97208898 |
| 74 | MAP3K2 | 0.96192972 |
| 75 | KIT | 0.93980339 |
| 76 | PIM2 | 0.91014696 |
| 77 | STK38L | 0.88849249 |
| 78 | DMPK | 0.88048739 |
| 79 | PRKCQ | 0.87673975 |
| 80 | TNIK | 0.87634576 |
| 81 | LMTK2 | 0.86785091 |
| 82 | TAF1 | 0.86130850 |
| 83 | KSR1 | 0.86025929 |
| 84 | PTK2 | 0.85671625 |
| 85 | MET | 0.84876010 |
| 86 | SGK2 | 0.84264542 |
| 87 | KSR2 | 0.82923845 |
| 88 | ITK | 0.81382191 |
| 89 | CSF1R | 0.81324918 |
| 90 | PAK2 | 0.80051055 |
| 91 | PLK2 | 0.79310116 |
| 92 | JAK2 | 0.79022246 |
| 93 | FGFR3 | 0.78878056 |
| 94 | ADRBK2 | 0.78831631 |
| 95 | BLK | 0.77921149 |
| 96 | MTOR | 0.77082738 |
| 97 | BMPR1B | 0.76255528 |
| 98 | BMX | 0.75769035 |
| 99 | CSK | 0.75675726 |
| 100 | GRK5 | 0.70882803 |
| 101 | MAP3K8 | 0.70842960 |
| 102 | ADRBK1 | 0.70138499 |
| 103 | TRPM7 | 0.69497743 |
| 104 | CHUK | 0.68446311 |
| 105 | PAK4 | 0.68094920 |
| 106 | PDK2 | 0.67085320 |
| 107 | PAK3 | 0.65128236 |
| 108 | KDR | 0.63448749 |
| 109 | SGK3 | 0.63327333 |
| 110 | TNK2 | 0.62528004 |
| 111 | MAPK15 | 0.62276737 |
| 112 | PRKG2 | 0.61259510 |
| 113 | SIK3 | 0.60663130 |
| 114 | IKBKE | 0.60235483 |
| 115 | DYRK3 | 0.59501685 |
| 116 | HIPK2 | 0.59393780 |
| 117 | PDK1 | 0.59194274 |
| 118 | BTK | 0.58998982 |
| 119 | MAPKAPK3 | 0.57998151 |
| 120 | IRAK1 | 0.57078482 |
| 121 | IRAK4 | 0.56926189 |
| 122 | PASK | 0.56343415 |
| 123 | PDGFRB | 0.55209142 |
| 124 | IKBKB | 0.55194425 |
| 125 | HCK | 0.54859798 |
| 126 | TAOK1 | 0.53948099 |
| 127 | ERBB4 | 0.52836186 |
| 128 | NUAK1 | 0.52048256 |
| 129 | MARK3 | 0.50058445 |
| 130 | DDR2 | 0.49741122 |
| 131 | MAP3K5 | 0.49716928 |
| 132 | FES | 0.49008945 |
| 133 | TGFBR1 | 0.45976466 |
| 134 | NEK6 | 0.45247795 |
| 135 | PIM1 | 0.45242129 |
| 136 | TEC | 0.44785314 |
| 137 | RET | 0.44272692 |
| 138 | PRPF4B | 0.44055029 |
| 139 | EGFR | 0.44011355 |
| 140 | CDC42BPA | 0.43117948 |
| 141 | GSK3A | 0.42585425 |
| 142 | STK4 | 0.42036029 |
| 143 | GRK1 | 0.41986685 |
| 144 | MAP3K1 | 0.41139834 |
| 145 | MAP2K1 | 0.41076451 |
| 146 | MAPK11 | 0.40362917 |
| 147 | ABL1 | 0.40190026 |
| 148 | IGF1R | 0.40003316 |
| 149 | PAK1 | 0.39973224 |
| 150 | MAP3K7 | 0.39889642 |
| 151 | LCK | 0.39131225 |
| 152 | CDK9 | 0.37475025 |
| 153 | CAMK1G | 0.37349810 |
| 154 | WNK4 | 0.36723988 |
| 155 | RPS6KB2 | 0.35349768 |
| 156 | MAPKAPK2 | 0.35290532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.96292855 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 2.77555525 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77324841 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.76701977 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67773049 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52129440 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.38446917 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37487935 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.34805268 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.34035243 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33409815 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.23799149 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19745252 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.14310999 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10482268 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05333462 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.00168754 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97254602 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.85762373 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84581080 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82728767 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82447072 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81562775 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.80659726 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.79345328 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.75646832 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.72304750 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71845342 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.70121150 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.63547558 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61892746 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60691695 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60188657 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58268617 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49581131 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47836471 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44484027 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41453883 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37933363 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.34892720 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.34653115 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.34153003 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.29312604 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.27827574 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26787580 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.25035047 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23313041 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22249299 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21985361 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18153685 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18088119 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16074777 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10202800 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09932638 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08992242 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08450981 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07709498 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06759710 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05886629 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99856971 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.99347764 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99054634 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99041444 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98952563 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98325187 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96540981 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.95448013 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94969978 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.94489350 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.93555960 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.90289042 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90224330 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90086462 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.89729352 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87119775 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87067920 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86318609 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85509582 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84176857 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.83925724 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83906072 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83557242 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83098356 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83000526 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82268115 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81742680 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.80512039 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79701181 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79296900 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78064841 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.76667079 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76318838 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75965694 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.75435046 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75322301 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75306095 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74777911 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74662908 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74628272 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.74313421 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73233997 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73075483 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72639085 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72599936 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72535202 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72430616 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71435306 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71266763 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.70516506 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70449312 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69798936 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69269463 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.69082689 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67062213 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66778859 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66001845 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65516838 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65140718 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63280799 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62640142 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62263932 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.62170616 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.60773288 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60381384 |
| 125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58975122 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57517058 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57290710 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57202489 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.56999334 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55438048 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.55144376 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53740597 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52832048 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52810076 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52084193 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51667102 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51148919 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50815838 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50634759 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49748534 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49698176 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49617153 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48694447 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.48311145 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.47352546 |
| 146 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46678573 |
| 147 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46080699 |
| 148 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45611196 |
| 149 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45490094 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.45484636 |
| 151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45100763 |
| 152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44809916 |
| 153 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44435469 |
| 154 | Protein export_Homo sapiens_hsa03060 | 0.44403844 |
| 155 | Tuberculosis_Homo sapiens_hsa05152 | 0.44126196 |
| 156 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44033821 |
| 157 | Phototransduction_Homo sapiens_hsa04744 | 0.43564724 |
| 158 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42631177 |
| 159 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42431463 |
| 160 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42206169 |
| 161 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39579023 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37703504 |

